Importer of Controlled Substances Application: Restek Corporation, 13887-13892 [2025-05282]

Download as PDF 13887 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 27, 2025. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.’’ SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may submit electronic comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on October 2, 2024, Royal Beverages, LLC, 1821 Linglestown Road, Harrisburg, Pennsylvania 17110–3323 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 28, 2025. Such persons may also file a written request for a hearing on the application on or before April 28, 2025. DATES: Drug Enforcement Administration The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. [Docket No. DEA–1525] SUPPLEMENTARY INFORMATION: Controlled substance Marihuana Extract ........... Marihuana ........................ Tetrahydrocannabinols .... Psilocybin ........................ Drug code Schedule 7350 7360 7370 7437 I I I I Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–05281 Filed 3–26–25; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Importer of Controlled Substances Application: Restek Corporation Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on February 20, 2025, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823–8433, applied to be registered as an importer of the following basic class(es) of controlled substance(s): lotter on DSK11XQN23PROD with NOTICES1 Controlled Substance Drug Code Amineptine ....................................................................................................................................................................... Mesocarb ......................................................................................................................................................................... 3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. Para-Methoxymethamphetamine (PMMA), 1-(4–1245 I N methoxyphenyl)-N-methylpropan-2-amine .......................... Pentedrone (a-methylaminovalerophenone) ................................................................................................................... VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1 1219 1227 1233 1235 1237 1238 1245 1246 Schedule I I I I I I I I 13888 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled Substance Drug Code Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine) ...................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Fenethylline ..................................................................................................................................................................... Aminorex .......................................................................................................................................................................... 4-Methylaminorex (cis isomer) ........................................................................................................................................ 4,4′-Dimethylaminorex ..................................................................................................................................................... Gamma Hydroxybutyric Acid ........................................................................................................................................... Methaqualone .................................................................................................................................................................. Mecloqualone .................................................................................................................................................................. JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. SR–18 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) 7008 I N SR–18 and RCS–8 indole) SR–19 (1–P ................... ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) ............. AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB–144 tetramethylcyclopropyl)methanone ............................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate). AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ......................................... THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...................... AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) ........................................................... 5F–MDMB–PICA ............................................................................................................................................................. MDMB–CHMICA, MMB–CHMINACA .............................................................................................................................. Methyl 2–7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) ............................................ MMB–CHMICA ................................................................................................................................................................ FUB–AKB48; FUB–APINACA; AKB48 N-(4–FLUOROBENZYL) ................................................................................... APINACA and AKB48 ..................................................................................................................................................... 5F–APINACA, 5F–AKB48 ............................................................................................................................................... JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 1-(5-Fluoropentyl)-1H-indazole-3-carboxamide ............................................................................................................... 5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ............... 4–CN–CUMYL–BUTINACA ............................................................................................................................................. SR–19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................................................................ JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... UR–144 ............................................................................................................................................................................ JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................... PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 4-methyl-alpha-ethylaminopentiophenone (4–MEAP) ..................................................................................................... N-ethylhexedrone ............................................................................................................................................................ Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE, methoxetamine (methoxetamine) .................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... Lysergic acid diethylamide .............................................................................................................................................. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine ............................................................................................................... Marihuana extract ............................................................................................................................................................ Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Parahexyl ......................................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2C–T–2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) .......................................................................................... 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1 Schedule 1248 1249 1258 1475 1478 1480 1503 1585 1590 1595 2010 2565 2572 6250 7008 7010 7011 7012 7014 7019 7020 7021 I I I I I I I I I I I I I I I I I I I I I I 7023 7024 7025 7031 7032 7033 7034 7035 7036 7041 7042 7043 7044 7047 7048 7049 7081 7083 7085 7089 7104 7118 7122 7144 7173 7200 7201 7203 7221 7222 7225 7245 7246 7249 7260 7286 7297 7298 7315 7348 7350 7360 7370 7374 7381 7385 7390 7391 7392 7395 7396 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 13889 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled Substance Drug Code JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. Peyote .............................................................................................................................................................................. 5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ............................................................................................ 4´-methyl-alpha-pyrrolidinohexiophenone (MPHP) .......................................................................................................... N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ N-Methyl-3-piperidyl benzilate ......................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ..................................................................................................... 2C–H (2-(2,5-Dimethoxyphenyl) ethanamine) ................................................................................................................. 2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................ 2C–C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .................................................................................................. 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .................................................................................................... 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ............................................................................................. 2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................................ 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................................ 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .................................................... Alpha-Pyrrolidinohexanophenone .................................................................................................................................... a-PVP (alpha-pyrrolidinopentiophenone) ........................................................................................................................ a-PBP (alpha-pyrrolidinobutiophenone) .......................................................................................................................... Ethylone ........................................................................................................................................................................... PV8, alpha-Pyrrolidinoheptaphenone .............................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... Acetyldihydrocodeine ....................................................................................................................................................... Benzylmorphine ............................................................................................................................................................... Codeine-N-oxide .............................................................................................................................................................. Cyprenorphine ................................................................................................................................................................. Desomorphine ................................................................................................................................................................. Etorphine (except HCl) .................................................................................................................................................... Codeine methylbromide ................................................................................................................................................... Brorphine ......................................................................................................................................................................... Dihydromorphine ............................................................................................................................................................. Difenoxin .......................................................................................................................................................................... Heroin .............................................................................................................................................................................. Hydromorphinol ............................................................................................................................................................... Methyldesorphine ............................................................................................................................................................ Methyldihydromorphine ................................................................................................................................................... Morphine methylbromide ................................................................................................................................................. Morphine methylsulfonate ............................................................................................................................................... Morphine-N-oxide ............................................................................................................................................................ Myrophine ........................................................................................................................................................................ Nicocodeine ..................................................................................................................................................................... Nicomorphine ................................................................................................................................................................... Normorphine .................................................................................................................................................................... Pholcodine ....................................................................................................................................................................... Thebacon ......................................................................................................................................................................... Acetorphine ...................................................................................................................................................................... Drotebanol ....................................................................................................................................................................... VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1 7398 7399 7400 7401 7402 7404 7405 7411 7415 7431 7432 7433 7434 7435 7437 7438 7439 7443 7446 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7547 7548 7694 9051 9052 9053 9054 9055 9056 9070 9098 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 13890 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled Substance Drug Code U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .................................................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Betameprodine ................................................................................................................................................................ Betamethadol ................................................................................................................................................................... Betaprodine ..................................................................................................................................................................... Clonitazene ...................................................................................................................................................................... Dextromoramide .............................................................................................................................................................. Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitronitro- 1H-benzimidazol-1-yl)ethan-1-amine) ..................... Diampromide ................................................................................................................................................................... Diethylthiambutene .......................................................................................................................................................... Dimenoxadol .................................................................................................................................................................... Dimepheptanol ................................................................................................................................................................. Dimethylthiambutene ....................................................................................................................................................... Dioxaphetyl butyrate ........................................................................................................................................................ Dipipanone ....................................................................................................................................................................... Ethylmethylthiambutene .................................................................................................................................................. Etonitazene ...................................................................................................................................................................... Etoxeridine ....................................................................................................................................................................... Furethidine ....................................................................................................................................................................... Hydroxypethidine ............................................................................................................................................................. Ketobemidone .................................................................................................................................................................. Levomoramide ................................................................................................................................................................. Levophenacylmorphan .................................................................................................................................................... Morpheridine .................................................................................................................................................................... Noracymethadol ............................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Normethadone ................................................................................................................................................................. Norpipanone .................................................................................................................................................................... Phenadoxone ................................................................................................................................................................... Phenampromide .............................................................................................................................................................. Phenoperidine .................................................................................................................................................................. Piritramide ........................................................................................................................................................................ Proheptazine .................................................................................................................................................................... Properidine ...................................................................................................................................................................... Racemoramide ................................................................................................................................................................ Trimeperidine ................................................................................................................................................................... Phenomorphan ................................................................................................................................................................ Propiram .......................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. Tilidine ............................................................................................................................................................................. Butonitazene .................................................................................................................................................................... Flunitazene ...................................................................................................................................................................... METONITAZENE ............................................................................................................................................................. N–PYRROLIDINO ETONITAZENE; ETONITAZEPYNE ................................................................................................. PROTONITAZENE .......................................................................................................................................................... METODESNITAZENE ..................................................................................................................................................... ETODESNITAZENE; ETAZENE ..................................................................................................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-Methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................... Para-Methylfentanyl ......................................................................................................................................................... 4′-Methyl Acetyl fentanyl ................................................................................................................................................. Ortho-Methyl methoxyacetyl fentanyl .............................................................................................................................. Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Butyryl Fentanyl ............................................................................................................................................................... Para-fluorobutyryl fentanyl ............................................................................................................................................... 4-Fluoroisobutyryl fentanyl .............................................................................................................................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... Para-chloroisobutyryl fentanyl ......................................................................................................................................... Isobutyryl fentanyl ............................................................................................................................................................ Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9608 9609 9611 9612 9613 9614 9615 9616 9617 9618 9619 9621 9622 9623 9624 9625 9626 9627 9628 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9751 9756 9757 9758 9759 9764 9765 9811 9812 9813 9814 9815 9816 9817 9819 9820 9821 9822 9823 9824 9825 9826 9827 9830 9831 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 13891 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled Substance Drug Code Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Furanyl fentanyl ............................................................................................................................................................... Thiofentanyl ..................................................................................................................................................................... Beta-hydroxythiofentanyl ................................................................................................................................................. Para-methoxybutyryl fentanyl .......................................................................................................................................... Ocfentanil ......................................................................................................................................................................... Thiofuranyl fentanyl ......................................................................................................................................................... Valeryl fentanyl ................................................................................................................................................................ Phenyl fentanyl ................................................................................................................................................................ Beta′-Phenyl fentanyl ...................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ......................................................................... Crotonyl fentanyl .............................................................................................................................................................. Cyclopropyl Fentanyl ....................................................................................................................................................... ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide; also known as 2fluorobutyryl fentanyl). Cyclopentyl fentanyl ........................................................................................................................................................ Ortho-Methyl acetylfentanyl ............................................................................................................................................. Fentanyl related compounds as defined in 21 CFR 1308.11(h) ..................................................................................... Fentanyl Carbamate ........................................................................................................................................................ ORTHO–FLUOROACRYL FENTANYL ........................................................................................................................... ORTHO–FLUOROISOBUTYRYL FENTANYL ................................................................................................................ Para-Fluoro furanyl fentanyl ............................................................................................................................................ 2′-Fluoro ortho-fluorofentanyl .......................................................................................................................................... Beta-Methyl fentanyl ........................................................................................................................................................ Zipeprol ............................................................................................................................................................................ Amphetam ....................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Lisdexamfetamine ............................................................................................................................................................ Phenmetrazine ................................................................................................................................................................. Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA). Nabilone ........................................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ Phencyclidine ................................................................................................................................................................... ANPP (4-Anilino-N-phenethyl-4-piperidine) ..................................................................................................................... Norfentanyl ...................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Anileridine ........................................................................................................................................................................ Coca Leaves .................................................................................................................................................................... Cocaine ............................................................................................................................................................................ Codeine ........................................................................................................................................................................... Etorphine HCl .................................................................................................................................................................. Dihydrocodeine ................................................................................................................................................................ Oxycodone ....................................................................................................................................................................... Hydromorphone ............................................................................................................................................................... Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Hydrocodone ................................................................................................................................................................... Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Isomethadone .................................................................................................................................................................. Meperidine ....................................................................................................................................................................... Meperidine-intermediate-A .............................................................................................................................................. Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Metazocine ...................................................................................................................................................................... Oliceridine ........................................................................................................................................................................ Methadone ....................................................................................................................................................................... Methadone intermediate .................................................................................................................................................. Metopon ........................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Morphine .......................................................................................................................................................................... Oripavine ......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Dihydroetorphine ............................................................................................................................................................. VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1 Schedule 9832 9833 9834 9835 9836 9837 9838 9839 9840 9841 9842 9843 9844 9845 9846 I I I I I I I I I I I I I I I 9847 9848 9850 9851 9852 9853 9854 9855 9856 9873 1100 1105 1205 1631 1724 2125 2270 2315 2550 7365 I I I I I I I I I I II II II II II II II II II II 7379 7460 7471 8333 8366 8501 8603 9010 9020 9040 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9245 9250 9254 9260 9273 9300 9330 9333 9334 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II 13892 Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices Controlled Substance Schedule Opium, raw ...................................................................................................................................................................... Opium extracts ................................................................................................................................................................ Opium fluid extract .......................................................................................................................................................... Opium tincture ................................................................................................................................................................. Opium, powdered ............................................................................................................................................................ Opium, granulated ........................................................................................................................................................... Levo-alphacetylmethadol ................................................................................................................................................. Opium poppy ................................................................................................................................................................... Oxymorphone .................................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Poppy Straw Concentrate ............................................................................................................................................... Phenazocine .................................................................................................................................................................... Thiafentanil ...................................................................................................................................................................... Piminodine ....................................................................................................................................................................... Racemethorphan ............................................................................................................................................................. Racemorphan .................................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... Bezitramide ...................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... Moramide-intermediate .................................................................................................................................................... 9600 9610 9620 9630 9639 9640 9648 9650 9652 9668 9670 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 II II II II II II II II II II II II II II II II II II II II II II II II The company plans to import the listed controlled substances for the use in the manufacture of exempted certified reference materials. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Controlled substance Drug code Schedule Marihuana Extract ............. Marihuana ......................... Tetrahydrocannabinols ..... 7350 7360 7370 I I I Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–05282 Filed 3–26–25; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1521] Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: lotter on DSK11XQN23PROD with NOTICES1 Drug Code Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: VerDate Sep<11>2014 17:43 Mar 26, 2025 Jkt 265001 Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 27, 2025. Such persons may also file a written request for a hearing on the application on or before May 27, 2025. DATES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on February 25, 2025, Royal Emerald Pharmaceuticals, 14011 Palm Drive, Building B, Desert Hot Springs, California 92240–6845, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 I The company plans to bulk manufacture the listed controlled substance to provide Marihuana (Cannabis) as botanical raw material and/or active pharmaceutical ingredients (API) to Drug Enforcement Administration-registered researchers and manufacturers. No other activities for these drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–05279 Filed 3–26–25; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration Thomas Andr’e Endicott, D.D.S.; Decision and Order On March 26, 2024, the Drug Enforcement Administration (DEA or Government) issued an Order to Show Cause (OSC) to Thomas Andr’e Endicott, D.D.S., of Salt Lake City, Utah (Registrant). Request for Final Agency Action (RFAA), Exhibit (RFAAX) 1, at 1, 3. The OSC proposed the revocation of Registrant’s Certificate of Registration No. FE3865029, alleging that Registrant’s registration should be revoked because Registrant is ‘‘currently without authority to handle controlled E:\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 90, Number 58 (Thursday, March 27, 2025)]
[Notices]
[Pages 13887-13892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05282]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1525]


Importer of Controlled Substances Application: Restek Corporation

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Restek Corporation has applied to be registered as an importer 
of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY 
INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 28, 2025. Such persons may also file a written request for a 
hearing on the application on or before April 28, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 20, 2025, Restek Corporation, 110 Benner 
Circle, Bellefonte, Pennsylvania 16823-8433, applied to be registered 
as an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
           Controlled Substance               Drug Code       Schedule
------------------------------------------------------------------------
Amineptine...............................            1219  I
Mesocarb.................................            1227  I
3-Fluoro-N-methylcathinone (3-FMC).......            1233  I
Cathinone................................            1235  I
Methcathinone............................            1237  I
4-Fluoro-N-methylcathinone (4-FMC).......            1238  I
Para-Methoxymethamphetamine (PMMA), 1-(4-            1245  I
 1245 I N methoxyphenyl)-N-methylpropan-2-
 amine.
Pentedrone ([alpha]-                                 1246  I
 methylaminovalerophenone).

[[Page 13888]]

 
Mephedrone (4-Methyl-N-methylcathinone)..            1248  I
4-Methyl-N-ethylcathinone (4-MEC)........            1249  I
Naphyrone................................            1258  I
N-Ethylamphetamine.......................            1475  I
Methiopropamine (N-methyl-1-(thiophen-2-             1478  I
 yl)propan-2- 1478 I N amine).
N,N-Dimethylamphetamine..................            1480  I
Fenethylline.............................            1503  I
Aminorex.................................            1585  I
4-Methylaminorex (cis isomer)............            1590  I
4,4'-Dimethylaminorex....................            1595  I
Gamma Hydroxybutyric Acid................            2010  I
Methaqualone.............................            2565  I
Mecloqualone.............................            2572  I
JWH-250 (1-Pentyl-3-(2-                              6250  I
 methoxyphenylacetyl) indole).
SR-18 (1-Cyclohexylethyl-3-(2-                       7008  I
 methoxyphenylacetyl) 7008 I N SR-18 and
 RCS-8 indole) SR-19 (1-P.
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-             7010  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-             7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1-                  7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-           7014  I
  7014 I N FUB-144
 tetramethylcyclopropyl)methanone.
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..            7019  I
MDMB-FUBINACA (Methyl 2-(1-(4-                       7020  I
 fluorobenzyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-           7021  I
 (4-fluorobenzyl)-1Hindazole-3-
 carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-           7023  I
 2-yl)-1-pentyl-1H-indazole-)3-
 carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-            7024  I
 3-yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3methyl-1-                  7025  I
 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
 indazole-3-carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-                  7031  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-              7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-             7033  I
 indazole-3-carboxamido)-3-
 methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-              7034  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-               7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-           7036  I
 carboxamido) 3,3-dimethylbutanoate).
5F-MDMB-PICA.............................            7041  I
MDMB-CHMICA, MMB-CHMINACA................            7042  I
Methyl 2-7043 I N (1-(4-fluorobutyl)-1H-             7043  I
 indazole-3-carboxamido)-
 3,3dimethylbutanoate).
MMB-CHMICA...............................            7044  I
FUB-AKB48; FUB-APINACA; AKB48 N-(4-                  7047  I
 FLUOROBENZYL).
APINACA and AKB48........................            7048  I
5F-APINACA, 5F-AKB48.....................            7049  I
JWH-081 (1-Pentyl-3-(1-(4-                           7081  I
 methoxynaphthoyl) indole).
1-(5-Fluoropentyl)-1H-indazole-3-                    7083  I
 carboxamide.
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-            7085  I
 phenylpropan-2-yl)-1H-pyrrolo[2,3-
 b]pyridine-3-carboxamide).
4-CN-CUMYL-BUTINACA......................            7089  I
SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl]              7104  I
 indole.
JWH-018 (also known as AM678) (1-Pentyl-3-           7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-                     7122  I
 naphthoyl) indole).
UR-144...................................            7144  I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..            7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-            7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-                     7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                              7203  I
 chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-               7221  I
 fluoropentyl)-1H-indole-3-carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-           7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                        7225  I
 fluoropentyl)-1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4-           7245  I
 MEAP).
N-ethylhexedrone.........................            7246  I
Alpha-ethyltryptamine....................            7249  I
Ibogaine.................................            7260  I
2-(ethylamino)-2-(3-                                 7286  I
 methoxyphenyl)cyclohexan-1-one 7286 I N
 MXE, methoxetamine (methoxetamine).
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                 7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                      7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide...............            7315  I
2,5-Dimethoxy-4-(n)-                                 7348  I
 propylthiophenethylamine.
Marihuana extract........................            7350  I
Marihuana................................            7360  I
Tetrahydrocannabinols....................            7370  I
Parahexyl................................            7374  I
Mescaline................................            7381  I
2C-T-2, (2-(4-Ethylthio-2,5-                         7385  I
 dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine..............            7390  I
4-Bromo-2,5-dimethoxyamphetamine.........            7391  I
4-Bromo-2,5-dimethoxyphenethylamine......            7392  I
4-Methyl-2,5-dimethoxyamphetamine........            7395  I
2,5-Dimethoxyamphetamine.................            7396  I

[[Page 13889]]

 
JWH-398 (1-Pentyl-3-(4-chloro-1-                     7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine.........            7399  I
3,4-Methylenedioxyamphetamine............            7400  I
5-Methoxy-3,4-methylenedioxyamphetamine..            7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine..            7402  I
3,4-Methylenedioxy-N-ethylamphetamine....            7404  I
3,4-Methylenedioxymethamphetamine........            7405  I
4-Methoxyamphetamine.....................            7411  I
Peyote...................................            7415  I
5-Methoxy-N-N-dimethyltryptamine.........            7431  I
Alpha-methyltryptamine...................            7432  I
Bufotenine...............................            7433  I
Diethyltryptamine........................            7434  I
Dimethyltryptamine.......................            7435  I
Psilocybin...............................            7437  I
Psilocyn.................................            7438  I
5-Methoxy-N,N-diisopropyltryptamine......            7439  I
4-chloro-alpha-pyrrolidinovalerophenone              7443  I
 (4-chloro-a-PVP).
4[acute]-methyl-alpha-                               7446  I
 pyrrolidinohexiophenone (MPHP).
N-Ethyl-1-phenylcyclohexylamine..........            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine........            7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine....            7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine...            7473  I
N-Ethyl-3-piperidyl benzilate............            7482  I
N-Methyl-3-piperidyl benzilate...........            7484  I
N-Benzylpiperazine.......................            7493  I
4-MePPP (4-Methyl-                                   7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)               7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)                7509  I
 ethanamine).
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine)            7517  I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl)                 7518  I
 ethanamine).
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl)               7519  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)               7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-                        7524  I
 propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                     7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)....            7535  I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-                7536  I
 methoxybenzyl) ethanamine).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-               7537  I
 methoxybenzyl) ethanamine).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-                 7538  I
 methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                     7540  I
 methylcathinone).
Butylone.................................            7541  I
Pentylone................................            7542  I
N-Ethylpentylone, ephylone (1-(1,3-                  7543  I
 benzodioxol-5-yl)-2-(ethylamino)-pentan-
 1-one).
Alpha-Pyrrolidinohexanophenone...........            7544  I
[alpha]-PVP (alpha-                                  7545  I
 pyrrolidinopentiophenone).
[alpha]-PBP (alpha-                                  7546  I
 pyrrolidinobutiophenone).
Ethylone.................................            7547  I
PV8, alpha-Pyrrolidinoheptaphenone.......            7548  I
AM-694 (1-(5-Fluoropentyl)-3-(2-                     7694  I
 iodobenzoyl) indole).
Acetyldihydrocodeine.....................            9051  I
Benzylmorphine...........................            9052  I
Codeine-N-oxide..........................            9053  I
Cyprenorphine............................            9054  I
Desomorphine.............................            9055  I
Etorphine (except HCl)...................            9056  I
Codeine methylbromide....................            9070  I
Brorphine................................            9098  I
Dihydromorphine..........................            9145  I
Difenoxin................................            9168  I
Heroin...................................            9200  I
Hydromorphinol...........................            9301  I
Methyldesorphine.........................            9302  I
Methyldihydromorphine....................            9304  I
Morphine methylbromide...................            9305  I
Morphine methylsulfonate.................            9306  I
Morphine-N-oxide.........................            9307  I
Myrophine................................            9308  I
Nicocodeine..............................            9309  I
Nicomorphine.............................            9312  I
Normorphine..............................            9313  I
Pholcodine...............................            9314  I
Thebacon.................................            9315  I
Acetorphine..............................            9319  I
Drotebanol...............................            9335  I

[[Page 13890]]

 
U-47700 (3,4-dichloro-N-[2-                          9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                         9551  I
 dimethylamino)cyclohexylmethyl]benzamide
 )).
MT-45 (1-cyclohexyl-4-(1,2-                          9560  I
 diphenylethyl)piperazine)).
Acetylmethadol...........................            9601  I
Allylprodine.............................            9602  I
Alphacetylmethadol except levo-                      9603  I
 alphacetylmethadol.
Alphameprodine...........................            9604  I
Alphamethadol............................            9605  I
Benzethidine.............................            9606  I
Betacetylmethadol........................            9607  I
Betameprodine............................            9608  I
Betamethadol.............................            9609  I
Betaprodine..............................            9611  I
Clonitazene..............................            9612  I
Dextromoramide...........................            9613  I
Isotonitazene (N,N-diethyl-2-(2-(4                   9614  I
 isopropoxybenzyl)-5-nitronitro- 1H-
 benzimidazol-1-yl)ethan-1-amine).
Diampromide..............................            9615  I
Diethylthiambutene.......................            9616  I
Dimenoxadol..............................            9617  I
Dimepheptanol............................            9618  I
Dimethylthiambutene......................            9619  I
Dioxaphetyl butyrate.....................            9621  I
Dipipanone...............................            9622  I
Ethylmethylthiambutene...................            9623  I
Etonitazene..............................            9624  I
Etoxeridine..............................            9625  I
Furethidine..............................            9626  I
Hydroxypethidine.........................            9627  I
Ketobemidone.............................            9628  I
Levomoramide.............................            9629  I
Levophenacylmorphan......................            9631  I
Morpheridine.............................            9632  I
Noracymethadol...........................            9633  I
Norlevorphanol...........................            9634  I
Normethadone.............................            9635  I
Norpipanone..............................            9636  I
Phenadoxone..............................            9637  I
Phenampromide............................            9638  I
Phenoperidine............................            9641  I
Piritramide..............................            9642  I
Proheptazine.............................            9643  I
Properidine..............................            9644  I
Racemoramide.............................            9645  I
Trimeperidine............................            9646  I
Phenomorphan.............................            9647  I
Propiram.................................            9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine.            9661  I
1-(2-Phenylethyl)-4-phenyl-4-                        9663  I
 acetoxypiperidine.
Tilidine.................................            9750  I
Butonitazene.............................            9751  I
Flunitazene..............................            9756  I
METONITAZENE.............................            9757  I
N-PYRROLIDINO ETONITAZENE; ETONITAZEPYNE.            9758  I
PROTONITAZENE............................            9759  I
METODESNITAZENE..........................            9764  I
ETODESNITAZENE; ETAZENE..................            9765  I
Acryl fentanyl (N-(1-phenethylpiperidin-4-           9811  I
 yl)-N-phenylacrylamide).
Para-Fluorofentanyl......................            9812  I
3-Methylfentanyl.........................            9813  I
Alpha-Methylfentanyl.....................            9814  I
Acetyl-alpha-methylfentanyl..............            9815  I
N-(2-fluorophenyl)-N-(1-                             9816  I
 phenethylpiperidin-4-yl)propionamide.
Para-Methylfentanyl......................            9817  I
4'-Methyl Acetyl fentanyl................            9819  I
Ortho-Methyl methoxyacetyl fentanyl......            9820  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-            9821  I
 4-yl)-N-phenylacetamide).
Butyryl Fentanyl.........................            9822  I
Para-fluorobutyryl fentanyl..............            9823  I
4-Fluoroisobutyryl fentanyl..............            9824  I
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-           9825  I
 phenylacetamide.
Para-chloroisobutyryl fentanyl...........            9826  I
Isobutyryl fentanyl......................            9827  I
Beta-hydroxyfentanyl.....................            9830  I
Beta-hydroxy-3-methylfentanyl............            9831  I

[[Page 13891]]

 
Alpha-methylthiofentanyl.................            9832  I
3-Methylthiofentanyl.....................            9833  I
Furanyl fentanyl.........................            9834  I
Thiofentanyl.............................            9835  I
Beta-hydroxythiofentanyl.................            9836  I
Para-methoxybutyryl fentanyl.............            9837  I
Ocfentanil...............................            9838  I
Thiofuranyl fentanyl.....................            9839  I
Valeryl fentanyl.........................            9840  I
Phenyl fentanyl..........................            9841  I
Beta'-Phenyl fentanyl....................            9842  I
N-(1-phenethylpiperidin-4-yl)-N-                     9843  I
 phenyltetrahydrofuran-2-carboxamide).
Crotonyl fentanyl........................            9844  I
Cyclopropyl Fentanyl.....................            9845  I
ortho-Fluorobutyryl fentanyl (N-(2-                  9846  I
 fluorophenyl)-N-(1- phenethylpiperidin-4-
 yl)butyramide; also known as 2-
 fluorobutyryl fentanyl).
Cyclopentyl fentanyl.....................            9847  I
Ortho-Methyl acetylfentanyl..............            9848  I
Fentanyl related compounds as defined in             9850  I
 21 CFR 1308.11(h).
Fentanyl Carbamate.......................            9851  I
ORTHO-FLUOROACRYL FENTANYL...............            9852  I
ORTHO-FLUOROISOBUTYRYL FENTANYL..........            9853  I
Para-Fluoro furanyl fentanyl.............            9854  I
2'-Fluoro ortho-fluorofentanyl...........            9855  I
Beta-Methyl fentanyl.....................            9856  I
Zipeprol.................................            9873  I
Amphetam.................................            1100  II
Methamphetamine..........................            1105  II
Lisdexamfetamine.........................            1205  II
Phenmetrazine............................            1631  II
Methylphenidate..........................            1724  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Dronabinol in an oral solution in a drug             7365  II
 product approved for marketing by the
 U.S. Food and Drug Administration (FDA).
Nabilone.................................            7379  II
1-Phenylcyclohexylamine..................            7460  II
Phencyclidine............................            7471  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)            8333  II
Norfentanyl..............................            8366  II
Phenylacetone............................            8501  II
1-Piperidinocyclohexanecarbonitrile......            8603  II
Alphaprodine.............................            9010  II
Anileridine..............................            9020  II
Coca Leaves..............................            9040  II
Cocaine..................................            9041  II
Codeine..................................            9050  II
Etorphine HCl............................            9059  II
Dihydrocodeine...........................            9120  II
Oxycodone................................            9143  II
Hydromorphone............................            9150  II
Diphenoxylate............................            9170  II
Ecgonine.................................            9180  II
Ethylmorphine............................            9190  II
Hydrocodone..............................            9193  II
Levomethorphan...........................            9210  II
Levorphanol..............................            9220  II
Isomethadone.............................            9226  II
Meperidine...............................            9230  II
Meperidine-intermediate-A................            9232  II
Meperidine intermediate-B................            9233  II
Meperidine intermediate-C................            9234  II
Metazocine...............................            9240  II
Oliceridine..............................            9245  II
Methadone................................            9250  II
Methadone intermediate...................            9254  II
Metopon..................................            9260  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Morphine.................................            9300  II
Oripavine................................            9330  II
Thebaine.................................            9333  II
Dihydroetorphine.........................            9334  II

[[Page 13892]]

 
Opium, raw...............................            9600  II
Opium extracts...........................            9610  II
Opium fluid extract......................            9620  II
Opium tincture...........................            9630  II
Opium, powdered..........................            9639  II
Opium, granulated........................            9640  II
Levo-alphacetylmethadol..................            9648  II
Opium poppy..............................            9650  II
Oxymorphone..............................            9652  II
Noroxymorphone...........................            9668  II
Poppy Straw Concentrate..................            9670  II
Phenazocine..............................            9715  II
Thiafentanil.............................            9729  II
Piminodine...............................            9730  II
Racemethorphan...........................            9732  II
Racemorphan..............................            9733  II
Alfentanil...............................            9737  II
Remifentanil.............................            9739  II
Sufentanil...............................            9740  II
Carfentanil..............................            9743  II
Tapentadol...............................            9780  II
Bezitramide..............................            9800  II
Fentanyl.................................            9801  II
Moramide-intermediate....................            9802  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the use in the manufacture of exempted certified reference materials. 
No other activities for these drug codes are authorized for this 
registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-05282 Filed 3-26-25; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.